| to = agomelatine
| stop =
* '''Before day 1:''' gradually reduce dosage of fluvoxamine to a maximum of 50 mg/day, when this dosage is > 50 mg/day. * '''Day 1:''' reduce dosage of fluvoxamine further to 25 mg/day.* '''Day 8:''' stop administration of fluvoxamine.{{stopFluvoxamine}}
| start =
* '''Day 8-14:''' a wash-out period of one week is necessary.
* '''Day 15:''' start administration of agomelatine after this period in a dosage of 25 mg/day.
* If ''' Day 22: ''' if necessary, the dosage of agomelatine can be increased to 50 mg/day.
| info =
* Fluvoxamine stops the metabolism of agomelatine via CYP1A2 (90%) and via CYP2C9/2C19 (10%).<ref name="agoswitch"> {{Pubmed|20196187|McAllister-Williams RH et al. The use of antidepressants in clinical practice: focus on agomelatine. Hum Psychopharmacol. 2010 Mar 1;25(2):95-102}}</ref>
{{reviewSSRI14d}}
}}